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INTRODUCTION
The UK’s Quality and Outcomes Framework 
(QOF) is the world’s largest pay-for-
performance scheme in primary care. It 
rewards general practices financially for 
delivering interventions and achieving 
patient outcomes using evidence-based 
indicators developed by the National 
Institute for Health and Care Excellence 
(NICE).1 Although the QOF is voluntary, 
nearly 99% of practices in England 
participate, on average deriving 10–15% of 
total practice income from the scheme.2 
The introduction of the QOF in 2004 was 
a part of a new national contract for GPs, 
driven by the need to respond to years 
of underinvestment in general practice 
compared with other parts of the health 
service, low morale among GPs, and 
variations in the quality of primary medical 
care.3,4 The QOF was intended to provide a 
mechanism to motivate GPs and to increase 
funding for their practices, and the vast 
majority of practices took up the opportunity 
for additional income. Evidence from the 
early years of the scheme suggested it 
reduced variations between practices in 
the delivery of incentivised interventions,5 
and contributed to progress towards better 
use of electronic records and nurse-
led multidisciplinary care of long-term 
conditions.3 After the first year of the QOF, 
most practices achieved near-maximum 
remuneration from the scheme.2
Arguably, then, the QOF achieved what it 
set out to do. But this may have come at a 
cost. It has been suggested that practices 
prioritise QOF-related activities at the 
expense of other aspects of care, because 
of their reliance on QOF income.6,7 
A decade after the introduction of the 
QOF, NHS strategy, set out in the 2014 
Five Year Forward View,8 is now focused 
on other challenges. These include finding 
new ways to manage people with long-
term conditions, whose care is estimated to 
consume 70% of health service resources.8 
Most clinical QOF indicators relate to the 
care of long-term conditions and are based 
on good evidence,4 but tend to be limited 
in scope, focusing on single, biomedical 
dimensions of care. Appendix 1 provides a 
brief description of the 68 QOF indicators 
relating to care of long-term conditions in 
2016–2017; the total number of indicators 
for that year was 77. 
In 2015, the Royal College of General 
Practitioners called for the replacement 
of the QOF to allow GPs ‘to focus on 
providing the best possible holistic care’.9 
NHS England, in April 2016, undertook to 
review the QOF, acknowledging that it may 
have ‘served its purpose’ and may be ‘a 
barrier to holistic management’.10 In early 
2017, the British Medical Association called 
for the QOF to be suspended to reduce 
bureaucratic pressures and free up clinical 
time.11 Scotland abolished the QOF in 2016.3
The Policy Research Unit in 
Commissioning and the Health Care 
System was commissioned to undertake a 
review, led by the Centre for Health Services 
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Studies at the University of Kent, to report 
in September 2016. The authors aimed to 
examine the evidence that the QOF has 
improved care and outcomes for patients 
with long-term conditions, including 
elements of care highlighted as priorities 
in the Five Year Forward View,8 such as 
coordinated and integrated care, holistic and 
personalised care, and self-care.
METHOD
The authors searched for reports of empirical 
quantitative research examining the 
effectiveness of the QOF in the management 
of long-term conditions, published in peer-
reviewed journals in English. They included 
studies of populations registered with GPs 
in the UK, and excluded studies of locally 
designed and implemented pay-for-
performance schemes, and studies of limited 
geographical scope (which were defined as 
examining data from fewer than four primary 
care trusts in England, or fewer than 100 
practices in Scotland) because of likely low 
generalisability. The authors included studies 
where the comparator was any other method 
of funding general practice, concurrent or 
historical, and, if there was no concurrent 
comparator, where the analysis controlled 
for underlying trends. They set no limits on 
outcomes except that they were measured 
quantitatively and related to patients with 
long-term conditions, including:
• measures of health or morbidity: 
biochemical and physiological measures, 
mortality, hospital admissions;
• biomedical aspects of delivery of care: 
diagnostics, plans, referrals, and ongoing 
monitoring, clinical interventions (for 
example, prescriptions, immunisations), 
consultation rates;
• broader aspects of care: coordination, 
continuity or integration of care, holistic 
care (that is, that considers multiple 
morbidity and social context, personalised 
for the patient), self-care; and 
• patient perspectives: patient experience, 
quality of life, or satisfaction.
The authors included randomised 
controlled trials, longitudinal studies 
where the analysis attempted to control 
for underlying trends, controlled before-
and-after studies, and systematic reviews 
of these. They excluded cross-sectional 
studies examining how outcomes varied 
according to QOF achievement, because 
of the lack of suitable controls, the near-
universal high level of achievement, and 
the high likelihood of confounding of 
associations between QOF achievement and 
outcome by other factors. The authors also 
excluded studies in which the researchers 
estimated or modelled outcomes rather 
than reporting empirical data (more details 
of the inclusion and exclusion criteria are 
available from the authors). The authors 
searched electronic databases (Cochrane 
Database, Medline, Embase, and Health 
Management Information Consortium) for 
studies published between 2004 (the year 
the QOF was introduced) and May 2016 (see 
Box 1 for search terms). They examined 
references of identified papers to search 
for further reports and asked experts for 
references to other relevant research. 
Two of the authors assessed suitability 
for inclusion for each abstract identified, 
and, where there was no consensus, asked 
a third author to adjudicate. Data were 
extracted independently from all papers by 
two authors.
The authors assessed quality of 
randomised controlled trials using 
adaptations of the Cochrane Collaboration’s 
tool,12 and longitudinal studies and 
systematic reviews using tools adapted 
from those developed by the National 
Institutes of Health.13,14
RESULTS
Identification and description of studies
Figure 1 shows the process of identification 
of studies. The three most recent systematic 
reviews asking the same questions as this 
review had search dates in 201215,16 and 
2015.17 These included 20 studies of the 
QOF in total.18–37 The systematic review with 
the 2015 search date17 identified two studies 
of the QOF,22,32 both of which had been 
published in 2011 and had been included in 
one or other of the two reviews with search 
dates in 2012. 
In all three reviews, while the authors set 
How this fits in
The usefulness of the Quality and 
Outcomes Framework (QOF) as a tool for 
promoting progress towards the vision 
of the Five Year Forward View for care of 
long-term conditions has been questioned. 
This systematic review found no convincing 
evidence that the QOF can promote better 
integrated care, personalised, holistic care, 
or self-care — or, indeed, improve any 
other outcomes in people with long-term 
conditions. The NHS should consider other 
ways of supporting general practice to 
deliver the vision of the Five Year Forward 
View.
Box 1. Search terms
Search 1 
• Quality Outcomes Framework (keyword) OR 
•  Quality and Outcomes Framework (keyword 
OR
• QOF (keyword)
Search 2 
•  Pay-for-performance (keyword) or 
Reimbursement (Medical Subject Heading 
(MeSH) term) AND
•  Primary health care (keyword) or Primary 
Health Care (MeSH term) OR
•  Primary medical care (keyword) or Family 
practice (MeSH term) OR
•  General practice (keyword) or General 
Practice (MESH term)
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few limits on outcomes, study outcomes 
were solely derived from either QOF 
indicators themselves or prescribing data, 
with two exceptions: one study examined 
adherence to British Thoracic Society 
spirometry standards36 and the other 
cardiovascular events in patients with 
hypertension.32 
The authors found five primary 
research studies meeting the search 
criteria published since 2012.38–42 The first 
examined trends in mortality rates for 
conditions covered by the QOF, comparing 
the UK with other high-income countries 
with no pay-for-performance schemes in 
primary care.38 The others examined the 
effect of introducing the QOF on patient 
management and outcomes, either 
nationally,39 or in samples of practices 
participating in the UK General Practice 
Research Database (GPRD) or Clinical 
Practice Research Datalink (CPRD) (627 UK 
practices,40 516 UK practices,41 148 English 
practices42). 
The studies’ outcomes were: mortality 
from long-term conditions;38 hospital 
admissions for a range of QOF and non-QOF 
conditions;39 consultation rates in severe 
mental illness (SMI);40 prescribing in type 2 
diabetes;41 and a composite indicator derived 
from QOF data on processes and outcomes 
of care in type 2 diabetes.42 Because of a 
high degree of study heterogeneity, the 
authors carried out a narrative synthesis. 
Table 1 summarises the design and results 
of primary research studies.
None of the relevant studies identified 
by the systematic reviews, or the primary 
studies published since 2012, examined the 
effect of the QOF on broader aspects of care 
or patient perspectives. 
Quality 
The systematic reviews were of good quality. 
Due to the nature of the intervention, the 
primary research studies were all before-
and-after studies using interrupted time 
series or difference-in-differences methods 
and, as such, were of good quality for 
observational studies. However, because 
of the study designs, the authors cannot be 
sure that the QOF was responsible for any 
change in outcomes. 
Findings 
Systematic reviews. The first systematic 
review concluded that the QOF had had a 
limited impact on health outcomes.15 The 
second systematic review concluded that 
the effect of pay-for-performance remained 
uncertain.16 The third systematic review 
concluded that there was limited evidence 
of the effects of financial incentives.17
Primary research. The study examining 
trends in mortality in the UK compared with 
other countries found no effect of the QOF, 
although the synthetic control approach43 
adopted in the study required the use of 
conservative tests for statistical inference.38 
The study examining emergency admissions 
before and after the introduction of the 
QOF found that the trend of increasing 
emergency hospital admission rates (which 
increased overall by 34% between 2004 and 
2010) was modestly lower for conditions 
incentivised in the QOF compared with 
conditions that were not incentivised in the 
QOF, by 3% in the first year rising to 8% in 
2010.39 The difference was mainly driven by 
relative reductions in emergency admission 
rates for coronary heart disease. 
The study examining consultation rates 
found a trend of increasing rates overall 
during the period, with a small step change 
in 2004; the rate of increase was greater in 
people with SMI than overall.40 The face-
to-face consultation rate in SMI increased 
from about nine to 11 per patient per year 
from 2000 to 2011, and in other people it 
stayed stable at about five per patient per 
year over the same period. 
Records identified through 
database searching 
(n = 445)
Records identified from
other sources 
(n = 16)
Records screened 
(n = 461)
Full-text articles assessed 
for eligibility 
(n = 81)
Systematic 
reviews
(n = 3)
Primary 
studies 
(n = 5)
Excluded (n = 380):
Duplicates (n = 268)
Too old (n = 11)
Commentary articles (n = 13)
Did not meet design criteria (n = 7)
Pay-for-performance only one part of 
larger intervention (n = 2)
Not relevant (n = 79)
Excluded (n = 73):
Not relevant (n = 13)
Commentary articles (n = 14)
Systematic reviews published before 
2012 (n = 3)
Included in an included systematic 
review (n = 1)
Did not meet design criteria (n = 22)
Studies of pay-for-performance in 
other countries (n = 7)
Not about long-term conditions (n = 1)
Local projects (n = 12)
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Figure 1. Search process and results.
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The study of prescribing in type 2 diabetes 
found a modest increase in prescribing 
of antidiabetic medication (changing the 
direction of the trend of decreasing initiation 
rates to increasing initiation rates) after the 
introduction of the QOF.41 The increase was 
sustained at a similar rate until 2008. 
The study examining effects on a 
composite indicator of process and 
outcomes in type 2 diabetes found a modest 
improvement of 14% over and above the 
underlying trend in the first year after the 
introduction of the QOF, declining to 8% in 
the third year.42 Table 1 summarises the 
results of the studies. 
DISCUSSION
Summary
The authors found evidence that the 
QOF may be associated with a modest 
reduction in emergency admission rates in 
long-term conditions, a modest increase 
in consultation rates in SMI, and modest 
improvements in certain limited aspects of 
the care of diabetes. They found no clear 
evidence that these changes have led to any 
effect on mortality. Because of the design of 
the studies, it is not possible to be sure that 
any of the positive effects seen are causally 
related to the QOF.
The authors found no evidence to suggest 
that the QOF influences, positively or 
negatively, other aspects of care, such as 
integration or coordination of care, holistic 
or personalised care, or self-care, nor any 
evidence of its effects on patients’ quality of 
life, experience, or satisfaction.
The QOF is unlikely to advance progress 
towards the vision of the Five Year Forward 
View for the care of long-term conditions. 
To deliver the aims of the Five Year Forward 
View, the NHS should consider more broadly 
— beyond what is measured by the QOF 
— what constitutes high-quality primary 
care for people with long-term conditions, 
and consider managing performance on 
this basis. In the context of a demoralised 
primary care workforce, it is important 
also to consider ways other than financial 
incentives to motivate primary care teams 
to deliver high-quality care. 
Strengths and limitations
To the authors’ knowledge, this review 
is the first to have specifically addressed 
the effect of the QOF on those aspects 
of care for long-term conditions that are 
prioritised by national policy. As with any 
systematic review, the authors’ conclusions 
are constrained by the limited quantity and 
quality of the primary research published to 
date. Although the search for quantitative 
research was comprehensive, the authors 
did not include qualitative research, which 
may provide other insights.
Research to date has not attempted to 
identify the effects of the QOF on any of 
the broader aspects of care for long-term 
conditions, having examined effects only 
on more easily measurable outcomes, for 
example, those collected as part of the QOF, 
or routinely available data on mortality, 
emergency admissions, consultation rates, 
and prescribing. The authors found no 
evidence of attempts to evaluate the QOF 
using validated measures of quality of care 
in general practice. Perhaps this is because 
defining and measuring quality of general 
practice is complex.44
The lack of effect of the QOF on mortality 
is surprising, given that the indicators 
are based on high-quality evidence of 
effectiveness of interventions. Why this is the 
case is not clear. The wider determinants of 
population health (including low income, 
experience of inequality or discrimination, 
or quality of air, education, housing, or work 
conditions45) may be much more important 
than the quality of care in determining 
mortality. Also, it is recognised that the 
effectiveness of interventions demonstrated 
in randomised controlled trials, which 
include highly selected study participants, 
is often diluted in routine clinical practice.46 
Perhaps non-incentivised activities are 
more important in determining mortality 
in the patient population. It is also possible 
that practices misreport performance 
so as to exaggerate the quality of care, 
although there is little evidence that this is 
a significant problem.47 
The authors found evidence that the QOF 
was associated with a modest slowing of 
the increase in emergency admissions for 
conditions for which care is incentivised by 
the QOF, and an increase in primary care 
attendances for people with serious mental 
illness. Whether the QOF is responsible for 
these is unclear; many other factors are 
likely to have influenced admission and 
attendance rates over the period, including 
changes in medical technology or access 
to other services, or national standards 
for management of long-term conditions. 
In any case, among interventions to 
prevent emergency admissions, pay-for-
performance is unlikely to be one of the 
most effective.48,49
It could be argued that some QOF 
indicators — in palliative care, cancer, 
SMI, dementia, and rheumatoid arthritis 
— incentivise multidisciplinary meetings, 
reviews, and care plans, considered 
necessary elements of holistic and 
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integrated care (as set out in recent 
guidance from NICE).50 However, to achieve 
the indicators, practices are not required 
to demonstrate that their activities ensure 
that holistic or integrated care has been 
delivered.
Implications for research and practice 
The authors found no convincing evidence 
that the QOF promotes better care and 
outcomes for people with long-term 
conditions. QOF may also have negative 
effects. If practices have achieved maximum 
or near maximum points under the scheme 
(which is true for most practices), they have 
little motivation to improve achievement 
further. It is likely that the QOF diverts 
practices and professionals from ways of 
providing high-quality primary care that is 
not QOF-related. Moreover, the QOF does 
not incentivise practices to improve care 
for patients with the most complex needs 
in primary care, because these are more 
likely to be excepted from the scheme.51 
Raising thresholds for achievement may be 
counterproductive — there is evidence that 
it leads to increased exception reporting, 
raising apparent achievement with no real 
increase in the desired activity.52 
The Chief Executive of the NHS 
announced in October 2016 that the 
QOF would be phased out.53 What would 
happen to the quality of primary care if 
the QOF is completely abolished is not 
clear, although it seems unlikely that 
standards would drop significantly, because 
the activities rewarded in the QOF are 
now firmly embedded in practice. There 
is some limited evidence to suggest that 
performance did not fall following the 
withdrawal of certain individual indicators 
from the scheme.54 Abolishing the QOF 
may also allow practices to prioritise other 
activities, which could lead to better care. 
The QOF provides a major component 
of practice income; if it were abolished, 
practices would need to be assured of a 
stable income. Losing this is likely to have 
detrimental effects on patient care and 
further worsen recruitment and retention 
in primary care, which is once again in a 
precarious position.55 
Alternative methods of rewarding good 
practice are being considered for new 
models of primary care.56 Any replacement 
for the QOF needs to consider the evidence 
of effectiveness of pay-for-performance in 
primary care, and the evidence of what 
motivates primary care professionals to 
provide high-quality care.57 Funding
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Appendix 1. QOF indicators 2016/2017 relating to care of long-term conditions
Long-term condition QOF code Brief description of indicator
Asthma AST001 Register of patients with asthma 
 AST002 Percentage of patients with asthma and measures of variability or reversibility recorded  
 AST003 Percentage of patients with asthma who have had control assessed 
 AST004 Percentage of patients with asthma with record of smoking status 
Atrial fibrillation AF001 Register of patients with atrial fibrillation 
 AF006 Percentage of patients with atrial fibrillation in whom stroke risk has been assessed  
 AF007 Anticoagulant therapy in those with atrial fibrillation and high risk of stroke
Cancer CAN001 Register of patients with cancer 
 CAN003 Percentage of patients with cancer who have been reviewed 
Chronic kidney disease (CKD) CKD001 Register of patients with chronic kidney disease
Chronic obstructive  COPD001 Register of patients with COPD 
pulmonary disease (COPD) COPD002 Percentage of patients with COPD with diagnosis confirmed by post-bronchodilator spirometry  
 COPD003 Percentage of patients with COPD who have had a review with assessment of breathlessness  
 COPD004 Percentage of patients with COPD with a record of forced expiratory volume in 1 second (FEV1) 
 COPD005 Percentage of patients with severe COPD with record of oxygen saturation 
 COPD007 Percentage of patients with COPD who have had influenza immunisation
Coronary heart disease (CHD) CHD001 Register of patients with CHD 
 CHD002 Percentage of patients with CHD with blood pressure 150/90 mmHg or less 
 CHD005 Percentage of patients with CHD taking aspirin, an alternative antiplatelet therapy, or an anticoagulant 
 CHD007 Percentage of patients with CHD who have had influenza immunisation 
Dementia DEM001 Register of patients with dementia 
 DEM004 Percentage of patients with dementia whose care plan has been reviewed face-to-face  
 DEM005 Percentage of patients with a new diagnosis of dementia with record of tests to exclude reversible cause 
Depression DEP003 Percentage of patients with new diagnosis of depression with review soon after diagnosis
Diabetes mellitus DM002 Percentage of patients with diabetes with blood pressure 150/90 mmHg or less 
 DM003 Percentage of patients with diabetes with blood pressure 140/80 mmHg or less 
 DM004 Percentage of patients with diabetes with total cholesterol 5 mmol/l or less 
 DM006 Percentage of patients with diabetes and nephropathy taking angiotensin converting  
   enzyme inhibitors or angiotensin receptor blockers (ACEIs or ARBs) 
 DM007 Percentage of patients with diabetes with glycosylated haemoglobin 59 mmol/mol or less  
 DM008 Percentage of patients with diabetes with glycosylated haemoglobin 64 mmol/mol or less  
 DM009 Percentage of patients with diabetes with glycosylated haemoglobin 75 mmol/mol or less  
 DM012 Percentage of QOF patients with diabetes with a record of a foot examination and foot risk classification 
 DM014 Patients newly diagnosed with diabetes referred to a structured education programme  
 DM017 Register of patients with diabetes 
 DM018 Percentage of patients with diabetes who have had influenza immunisation 
Epilepsy EP001 Register of patients with epilepsy
Heart failure HF001 Register of patients with heart failure 
 HF002 Percentage of patients with heart failure confirmed by an echocardiogram or by specialist assessment  
 HF003 Percentage of patients with heart failure taking ACEIs or ARBs 
 HF004 Percentage of patients with heart failure taking ACEIs or ARBs plus beta-blocker 
Hypertension HYP001 Register of patients with hypertension 
 HYP006 Percentage of patients with hypertension with blood pressure of 150/90 mmHg or less 
 CVD-PP001 Percentage of patients with hypertension and high cardiovascular risk treated with statins 
Learning disability LD003 Register of patients with learning disability
Mental health MH001 Register of patients with serious mental health problems  
 MH002 Percentage of patients with serious mental health problems with comprehensive care plan  
 MH003 Percentage of patients with serious mental health problems with record of blood pressure  
 MH007 Percentage of patients with serious mental health problems with record of alcohol consumption  
 MH008 Percentage of women with serious mental health problems with cervical screening test performed  
 MH009 Percentage of patients on lithium therapy having renal and thyroid function monitored  
 MH010 Percentage of patients on lithium therapy with lithium levels in therapeutic range 
… continued
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Appendix 1 continued. QOF indicators 2016/2017 relating to care of long-term conditions 
Osteoporosis OST002 Percentage of patients 50–74 with confirmed osteoporosis taking bone-sparing agent 
 OST004 Register of patients with osteoporosis  
 OST005 Percentage of patients aged >75 with osteoporosis taking bone-sparing agent
People with palliative care needs PC001 Register of patients in need of palliative care/support  
 PC002 Regular multidisciplinary case review meetings for people receiving palliative care
Peripheral arterial disease PAD001 Register of patients with peripheral arterial disease 
 PAD002 Percentage of patients with peripheral arterial disease with blood pressure 150/90 mmHg or less 
 PAD004 Percentage of patients with peripheral arterial disease taking aspirin or an alternative antiplatelet 
Rheumatoid arthritis RA001 Register of patients with rheumatoid arthritis 
 RA002 Percentage of patients with rheumatoid arthritis who have had a face-to-face review 
Stroke or transient  STIA001 Register of patients with STIA 
ischaemic attack (STIA) STIA003 Percentage of patients with STIA with blood pressure 150/90 mmHg or less 
 STIA007 Percentage of patients with non-haemorrhagic stroke or TIA taking antiplatelet agent, or anticoagulant 
 STIA008 Percentage of patients with STIA referred for further investigation  
 STIA009 Percentage of patients with STIA who have had influenza immunisation 
Several long-term conditions SMOK002 Percentage of patients with long-term conditions with record of smoking status  
 SMOK005 Percentage of smokers with long-term conditions offered smoking cessation support 
QOF = Quality and Outcomes Framework. 
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